Advances in the chemical and biological diversity of heterocyclic systems incorporating pyrimido[1,6-a]pyrimidine and pyrimido[1,6-c]pyrimidine scaffolds
dc.authorid | Dogru Mert, Basak/0000-0002-2270-9032 | |
dc.contributor.author | Elattar, Khaled M. | |
dc.contributor.author | Mert, Basak Dogru | |
dc.contributor.author | Monier, M. | |
dc.contributor.author | El-Mekabaty, Ahmed | |
dc.date.accessioned | 2025-01-06T17:44:56Z | |
dc.date.available | 2025-01-06T17:44:56Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Heterocycles incorporating a pyrimidopyrimidine scaffold have aroused great interest from researchers in the field of medical chemistry because of their privileged biological activities; they are used as anti-bacterial, antiviral, anti-tumor, anti-allergic, antihypertensive, anticancer, and hepatoprotective agents. Therefore, the present study aims to investigate the chemistry of heterocycles incorporating pyrimido[1,6-a]pyrimidine and pyrimido[1,6-c]pyrimidine skeletons and their biological characteristics. The main sections discuss (1) the synthetic routes to obtain substituted pyrimidopyrimidines, pyrimido[1,6-a]pyrimidin-diones, pyrimidoquinazolines, tricyclic, tetracyclic, and binary systems; (2) the reactivity of the substituents attached to the pyrimidopyrimidine skeleton, including thione and amide groups, nucleophilic substitutions, condensations, ring transformations, and coordination chemistry; (3) compounds of this class of heterocycles containing a significant characteristic scaffold and possessing a wide range of biological characteristics. | |
dc.identifier.doi | 10.1039/d0ra00411a | |
dc.identifier.endpage | 15492 | |
dc.identifier.issn | 2046-2069 | |
dc.identifier.issue | 26 | |
dc.identifier.pmid | 35558641 | |
dc.identifier.scopus | 2-s2.0-85084058501 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 15461 | |
dc.identifier.uri | https://doi.org/10.1039/d0ra00411a | |
dc.identifier.uri | https://hdl.handle.net/20.500.14669/3253 | |
dc.identifier.volume | 10 | |
dc.identifier.wos | WOS:000530037900047 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Royal Soc Chemistry | |
dc.relation.ispartof | Rsc Advances | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241211 | |
dc.subject | Endothelıal Growth-Factor | |
dc.subject | Pyrımıdıne-Derıvatıves | |
dc.subject | Condensed Heterocycles | |
dc.subject | Inhıbıtors | |
dc.subject | Chemıstry | |
dc.subject | Quınazolınes | |
dc.subject | Desıgn | |
dc.subject | Potent | |
dc.subject | Cyclızatıon | |
dc.subject | Antagonısts | |
dc.title | Advances in the chemical and biological diversity of heterocyclic systems incorporating pyrimido[1,6-a]pyrimidine and pyrimido[1,6-c]pyrimidine scaffolds | |
dc.type | Review Article |